Literature DB >> 21741939

Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice.

Ying Zhao1, Dan Ye, Jun Wang, Laura Calpe-Berdiel, Saaleha B R N Azzis, Theo J C Van Berkel, Miranda Van Eck.   

Abstract

Reducing the concentration of circulating lipids leads to decreased cardiovascular morbidity and mortality, but the dynamic remodeling that established atherosclerotic lesions undergo upon lipid lowering is poorly understood. Early or advanced lesions in the aortic root were induced by feeding LDL receptor knockout mice a high-fat, high-cholesterol Western-type diet for 5 or 9 weeks, respectively. In the first week after switching to a chow diet, plasma total cholesterol levels dropped 70%, but both early and advanced lesions increased in size. Early lesions grew because of an increase in smooth muscle cells; advanced lesions had an enlargement of absolute macrophage area. From 1 to 3 weeks after the diet switch, plasma total cholesterol levels were completely normalized, but the size of early lesions remained stable; however, advanced lesions became smaller due to a reduction of the absolute macrophage area. From 3 to 6 weeks, both early and advanced lesions progressed further, as a result of expansion of the absolute collagen and necrotic core area. In contrast, early lesions became proinflammatory, as evidenced by the increased infiltration of neutrophils and increased oxidative stress, probably caused by the activation of mast cells in the adventitia. Thus, the severity of atherosclerotic lesions affects their dynamic response to lipid lowering, indicating the importance of establishing stage-specific therapeutic protocols for the treatment of atherosclerosis.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741939      PMCID: PMC3157208          DOI: 10.1016/j.ajpath.2011.05.020

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Systematic review on the risk and benefit of different cholesterol-lowering interventions.

Authors:  H C Bucher; L E Griffith; G H Guyatt
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-02       Impact factor: 8.311

Review 2.  Mechanisms of oxidation, antioxidants, and atherosclerosis.

Authors:  S Parthasarathy; N Santanam
Journal:  Curr Opin Lipidol       Date:  1994-10       Impact factor: 4.776

3.  The dynamics of macrophage infiltration into the arterial wall during atherosclerotic lesion development in low-density lipoprotein receptor knockout mice.

Authors:  Dan Ye; Ying Zhao; Reeni B Hildebrand; Roshni R Singaraja; Michael R Hayden; Theo J C Van Berkel; Miranda Van Eck
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 4.  Collagen synthesis in atherosclerosis: too much and not enough.

Authors:  M D Rekhter
Journal:  Cardiovasc Res       Date:  1999-02       Impact factor: 10.787

5.  Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs.

Authors:  Peter Verhamme; Rozenn Quarck; Hiroyuki Hao; Michiel Knaapen; Steven Dymarkowski; Hilde Bernar; Johan Van Cleemput; Stefan Janssens; Jozef Vermylen; Giulio Gabbiani; Mark Kockx; Paul Holvoet
Journal:  Cardiovasc Res       Date:  2002-10       Impact factor: 10.787

6.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.

Authors:  Jaime Llodrá; Véronique Angeli; Jianhua Liu; Eugene Trogan; Edward A Fisher; Gwendalyn J Randolph
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

7.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

8.  Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

Authors:  M Aikawa; E Rabkin; Y Okada; S J Voglic; S K Clinton; C E Brinckerhoff; G K Sukhova; P Libby
Journal:  Circulation       Date:  1998-06-23       Impact factor: 29.690

Review 9.  Transgenic mouse models of lipoprotein metabolism and atherosclerosis.

Authors:  J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 10.  Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.

Authors:  B G Brown; X Q Zhao; D E Sacco; J J Albers
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

View more
  8 in total

1.  Hyperglycemia impairs atherosclerosis regression in mice.

Authors:  Nathalie Gaudreault; Nikit Kumar; Victor R Olivas; Delphine Eberlé; Kyle Stephens; Robert L Raffai
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

2.  Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.

Authors:  Jason S Knight; Wei Luo; Alexander A O'Dell; Srilakshmi Yalavarthi; Wenpu Zhao; Venkataraman Subramanian; Chiao Guo; Robert C Grenn; Paul R Thompson; Daniel T Eitzman; Mariana J Kaplan
Journal:  Circ Res       Date:  2014-01-14       Impact factor: 17.367

3.  Inducible ApoE gene repair in hypomorphic ApoE mice deficient in the low-density lipoprotein receptor promotes atheroma stabilization with a human-like lipoprotein profile.

Authors:  Delphine Eberlé; Fu Sang Luk; Roy Y Kim; Victor R Olivas; Nikit Kumar; Jessica M Posada; Kang Li; Nathalie Gaudreault; Joseph H Rapp; Robert L Raffai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-06-20       Impact factor: 8.311

4.  CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice.

Authors:  Matthew Riopel; Melanie Vassallo; Erik Ehinger; Jennifer Pattison; Karen Bowden; Holger Winkels; Maria Wilson; Ron de Jong; Sanjay Patel; Deepika Balakrishna; James Bilakovics; Andrea Fanjul; Artur Plonowski; Christopher J Larson; Klaus Ley; Pedro Cabrales; Joseph L Witztum; Jerrold M Olefsky; Yun Sok Lee
Journal:  Mol Metab       Date:  2018-12-02       Impact factor: 7.422

Review 5.  Mouse models of atherosclerosis and their suitability for the study of myocardial infarction.

Authors:  Pelin Golforoush; Derek M Yellon; Sean M Davidson
Journal:  Basic Res Cardiol       Date:  2020-11-30       Impact factor: 17.165

6.  Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells.

Authors:  Ya Peng; Jun Wang; Miao Zhang; Panpan Niu; Mengya Yang; Yilin Yang; Ying Zhao
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

7.  Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice.

Authors:  Nemanja Vujic; Stefanie Schlager; Thomas O Eichmann; Corina T Madreiter-Sokolowski; Madeleine Goeritzer; Silvia Rainer; Silvia Schauer; Angelika Rosenberger; Albert Woelfler; Prakash Doddapattar; Robert Zimmermann; Gerald Hoefler; Achim Lass; Wolfgang F Graier; Branislav Radovic; Dagmar Kratky
Journal:  Atherosclerosis       Date:  2015-11-02       Impact factor: 5.162

8.  Acyl-CoA:Diacylglycerol Acyltransferase 1 Expression Level in the Hematopoietic Compartment Impacts Inflammation in the Vascular Plaques of Atherosclerotic Mice.

Authors:  Nemanja Vujic; Jess Porter Abate; Stefanie Schlager; Tovo David; Dagmar Kratky; Suneil K Koliwad
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.